Binding of High-Mannose-Type Oligosaccharides and Synthetic Oligomannose Clusters to Human Antibody 2G12: Implications for HIV-1 Vaccine Design

Chemistry and Biology

Volumn 11, Issue 1, 2004, Pages 127-134

  Wang, Lai Xi ^a   Ni, Jiahong ^a   Singh, Suddham ^a   Li, Hengguang ^a  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1142306158     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(03)00299-0     Document Type: Article

References (35)

1. Burton D.R. A vaccine for HIV type 1. the antibody perspective Proc. Natl. Acad. Sci. USA. 94:1997;10018-10023.
2. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins. fusogens, antigens, and immunogens Science. 280:1998;1884-1888.
3. Wang L.X. Bioorganic approaches towards HIV vaccine design. Curr. Pharm. Des. 9:2003;1771-1787.
4. Conley A.J., Kessler J.A. II, Boots L.J., McKenna P.M., Schleif W.A., Emini E.A., Mark G.E. III, Katinger H., Cobb E.K., Lunceford S.M.et al. The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. J. Virol. 70:1996;6751-6758.
5. Parker C.E., Deterding L.J., Hager-Braun C., Binley J.M., Schulke N., Katinger H., Moore J.P., Tomer K.B. Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5. J. Virol. 75:2001;10906-10911.
6. Zwick M.B., Labrijn A.F., Wang M., Spenlehauer C., Saphire E.O., Binley J.M., Moore J.P., Stiegler G., Katinger H., Burton D.R.et al. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75:2001;10892-10905.
7. Stiegler G., Kunert R., Purtscher M., Wolbank S., Voglauer R., Steindl F., Katinger H. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 17:2001;1757-1765.
8. Burton D.R., Pyati J., Koduri R., Sharp S.J., Thornton G.B., Parren P.W., Sawyer L.S., Hendry R.M., Dunlop N., Nara P.L.et al. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science. 266:1994;1024-1027.
9. Roben P., Moore J.P., Thali M., Sodroski J., Barbas C.F. 3rd, Burton D.R. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68:1994;4821-4828.
10. Saphire E.O., Parren P.W., Pantophlet R., Zwick M.B., Morris G.M., Rudd P.M., Dwek R.A., Stanfield R.L., Burton D.R., Wilson I.A. Crystal structure of a neutralizing human IGG against HIV-1. a template for vaccine design Science. 293:2001;1155-1159.
11. Trkola A., Pomales A.B., Yuan H., Korber B., Maddon P.J., Allaway G.P., Katinger H., Barbas C.F. 3rd, Burton D.R., Ho D.D.et al. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J. Virol. 69:1995;6609-6617.
12. Trkola A., Purtscher M., Muster T., Ballaun C., Buchacher A., Sullivan N., Srinivasan K., Sodroski J., Moore J.P., Katinger H. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1996;1100-1108.
13. Mascola J.R., Stiegler G., VanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., Beary H., Hayes D., Frankel S.S., Birx D.L.et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:2000;207-210.
14. Baba T.W., Liska V., Hofmann-Lehmann R., Vlasak J., Xu W., Ayehunie S., Cavacini L.A., Posner M.R., Katinger H., Stiegler G.et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6:2000;200-206.
15. Sanders R.W., Venturi M., Schiffner L., Kalyanaraman R., Katinger H., Lloyd K.O., Kwong P.D., Moore J.P. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:2002;7293-7305.
16. Scanlan C.N., Pantophlet R., Wormald M.R., Ollmann Saphire E., Stanfield R., Wilson I.A., Katinger H., Dwek R.A., Rudd P.M., Burton D.R. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1→2 mannose residues on the outer face of gp120. J. Virol. 76:2002;7306-7321.
17. Leonard C.K., Spellman M.W., Riddle L., Harris R.J., Thomas J.N., Gregory T.J. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:1990;10373-10382.
18. Mizuochi T., Matthews T.J., Kato M., Hamako J., Titani K., Solomon J., Feizi T. Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J. Biol. Chem. 265:1990;8519-8524.
19. Geyer H., Holschbach C., Hunsmann G., Schneider J. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J. Biol. Chem. 263:1988;11760-11767.
20. Zhu X., Borchers C., Bienstock R.J., Tomer K.B. Mass spectrometric characterization of the glycosylation pattern of HIV- gp120 expressed in CHO cells. Biochemistry. 39:2000;11194-11204.
21. Shenoy S.R., Barrientos L.G., Ratner D.M., O'Keefe B.R., Seeberger P.H., Gronenborn A.M., Boyd M.R. Multisite and multivalent binding between cyanovirin-N and branched oligomannosides. calorimetric and NMR characterization Chem. Biol. 9:2002;1109-1118.
22. Bewley C.A., Kiyonaka S., Hamachi I. Site-specific discrimination by cyanovirin-N for alpha-linked trisaccharides comprising the three arms of Man(8) and Man(9). J. Mol. Biol. 322:2002;881-889.
23. Wyatt R., Kwong P.D., Desjardins E., Sweet R.W., Robinson J., Hendrickson W.A., Sodroski J.G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393:1998;705-711.
24. Wang L.X., Ni J., Singh S. Carbohydrate-centered maleimide cluster as a new type of templates for multivalent peptide assembling. synthesis of multivalent HIV-1 gp41 peptides Bioorg. Med. Chem. 11:2003;129-136.
25. Ni J., Singh S., Wang L.X. Synthesis of maleimide-activated carbohydrates as chemoselective tags for site-specific glycosylation of peptides and proteins. Bioconj. Chem. 14:2003;232-238.
26. Duncan R.J., Weston P.D., Wrigglesworth R. A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem. 132:1983;68-73.
27. Turnbull W.B., Stoddart J.F. Design and synthesis of glycodendrimers. J. Biotechnol. 90:2002;231-255.
28. Lindhorst T.K. Artificial multivalent sugar ligands to understand and manipulate carbohydrate-protein interactions. Top. Curr. Chem. 218:2002;200-235.
29. Roy R. Syntheses and some applications of chemically defined multivalent glycoconjugates. Curr. Opin. Struct. Biol. 6:1996;692-702.
30. Brewer C.F., Miceli M.C., Baum L.G. Clusters, bundles, arrays and lattices. novel mechanisms for lectin-saccharide-mediated cellular interactions Curr. Opin. Struct. Biol. 12:2002;616-623.
31. Kitov P.I., Sadowska J.M., Mulvey G., Armstrong G.D., Ling H., Pannu N.S., Read R.J., Bundle D.R. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature. 403:2000;669-672.
32. Calarese D.A., Scanlan C.N., Zwick M.B., Deechongkit S., Mimura Y., Kunert R., Zhu P., Wormald M.R., Stanfield R.L., Roux K.H.et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science. 300:2003;2065-2071.
33. Fujita K., Tanaka N., Sano M., Kato I., Asada Y., Takegawa K. Synthesis of neoglycoenzymes with homogeneous N-linked oligosaccharides using immobilized endo-beta-N-acetylglucosaminidase A. Biochem. Biophys. Res. Commun. 267:2000;134-138.
34. Lis H., Sharon N. Soybean agglutinin-a plant glycoprotein. Structure of the carbohydrate unit. J. Biol. Chem. 253:1978;3468-3476.
35. Huang C.C., Mayer H.E., Montgomery R. Microheterogeneity and paucidispersity of glycoproteins. Part I. The carbohydrate of chicken ovalbumin. Carbohydr. Res. 13:1970;127-137.